Next Article in Journal
Transcriptional Profiling Reveals the Wheat Defences against Fusarium Head Blight Disease Regulated by a NAC Transcription Factor
Next Article in Special Issue
Evaluation of Crocin Content and In Vitro Antioxidant and Anti-Glycation Activity of Different Saffron Extracts
Previous Article in Journal
A Genome-Wide Association Study Reveals Region Associated with Seed Protein Content in Cowpea
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Plants
Volume 12
Issue 14
10.3390/plants12142707
plants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Antioxidant Activity of Mistletoes (Viscum album and Other Species)

by
Marcello Nicoletti
Department of Environmental Biology, Foundation in Unam Sapientiam, Sapienza University of Rome, 00185 Rome, Italy
Plants 2023, 12(14), 2707; https://doi.org/10.3390/plants12142707
Submission received: 13 June 2023 / Revised: 17 July 2023 / Accepted: 17 July 2023 / Published: 20 July 2023
(This article belongs to the Special Issue Antioxidant Activity of Medicinal and Aromatic Plants 2023)
Browse Figures
Review Reports Versions Notes

Abstract

:
In addition to the European mistletoe, Viscum album, which is the most known and utilized one, there are several species commonly known as mistletoe. They are spread in various regions of the planet and are all characterized by hemiparasitism and epiphytic behaviour. The published studies evidence other similarities, including the sharing of important biological properties, with the common presence of antioxidant effects. However, whereas the European mistletoe is largely utilized in medical treatments, although with controversial aspects, the scientific knowledge and medical uses of other mistletoes are still insufficient. This review focuses on the controversial medical story of European mistletoe regarding its antioxidant activity and the potentiality of the other species named mistletoe pertaining to botanical families and genera different from Viscum.

1. Introduction

This review focuses on research concerning the antioxidant properties of mistletoes and considers their utilization in several fields and related pathologies. Mistletoes are special plants: unique in behaviour, chemical content, and metabolic processes, with a controversial human interest and utilization [1]. Their recent use in medicine as a complementary cancer treatment [2,3] is mainly based on evidence of general effects, like the antioxidant [4], anti-inflammatory [5], and immune-adjuvant [6] properties. Therefore, the literature on mistletoe extracts is an expanding area of research and now extends to the study of non-European species. Current studies vary from the safety of the extracts [7] to their utilization in several sectors of herbal interest, however, the main focus concerns metabolic stress.
The impact of chronic and long-term degenerative diseases on society will increase due to the elongation of life expectancy. Inflammation, oxidative stress, and immune responses are deeply involved in the current major causes of death, such as cardiovascular diseases and cancers [8,9,10]. Among the proposed solutions to protect against oxidative damage from biomolecules is the utilization of natural substances [11].
The reasons to consider natural products as potential treatments for chronic diseases were reported in the study by Dančík et al., based on computational evidence [12]. In the conclusion, they state: “our results indicate that targets of natural products are highly connected, much more so than genes implicated in human disease, … natural products tend to target proteins more essential to an organism than are disease genes”. In other words, natural products target proteins, which are more closely connected to the cellular and organism network than the gene targets implicated in human diseases, and therefore natural products affect more general protein networks essential to metabolism.
The reports on the antioxidant activity of mistletoe species are reported and discussed here, taking into consideration their multiple effects and controversial history. The traditional use of herbs implies that most of the attention will be directed towards the species of the Old Continent, as is the case with the Viscum album. However, there are other similar mistletoes worldwide, which could have similar or improved effects, as evidenced by the research. The controversial parabola of European mistletoe, from a poisonous plant to an ingredient of many drugs, is still ongoing. Its main tendencies, including utilization against chronic diseases in the elderly, are evidenced here as a platform for further steps. This review completes the previous one published in this journal concerning the anti-inflammatory activity of the Viscum album [13].
The references present in this review are the result of an extensive literature survey, comprehensive of more than 400 publications. Reports were obtained mainly on Google, PubMed, NCBI, and Scopus, following the Preferred Reporting Items for biological activity. The main keywords were “Viscum, mistletoe, antioxidant, anti-ROS, clinical trials, Santalaceae and related genera”.

1.1. The Mistletoe Plants

Plants commonly known as mistletoe correspond to different perennial dicotyledonous angiosperms species pertaining to the Rosales order. The most recognized mistletoe species are included in the genera Viscum, Phoradendron, Arceuthobium, Peraxilla, Loranthus, Amylotheca, Amyema, Taxillus, Psittacanthus, and Scurrula, which are spread throughout different botanical families. All of these are epiphytic species, meaning that they have no contact with soil, owing to their characteristic of hemiparasitism, which allows the mistletoes to extract raw sap from a host plant [14,15,16]. Parasitism of various types is present in at least 1% of plants but via different connections with the host [17]. Botanical studies, including a comparison between the physiology of mistletoe and the host, have expressed that, in the majority of cases, this is a symbiotic relationship in which there is an exchange of nutrients and a positive consequence for both species, except in conditions of drought, when there is strong competition for water [18,19,20]. As a consequence of this, mistletoe plants present a great variety of forms, shapes, and content, even between members of the same species, in accordance with habitat conditions and hosts, which influence the metabolome [21]. In 2023, a survey of the published research on the biological properties (hypotensive, anticancer, antimicrobial, analgesic, and anti-inflammatory capabilities) of the hydroalcoholic extracts of some species of Viscum have been reported [22], whereas, in this review, the antioxidant activity is evidenced.

1.2. The Viscum Mistletoes

The predominant variety of mistletoe plants is those belonging to the genus Viscum, which includes about 100 species (from 70 to 150, depending on the source of information) worldwide [23,24]. It is currently a member of the Santalaceae family, but it was previously considered a part of the Viscaceae and was originally part of the Loranthaceae. According to World Flora Online, there are 32 Viscum species across Africa, with around 30 of these exclusive to Madagascar [25]; they parasitize a variety of trees and shrubs of different families [26]. Some Viscum species are specialized to selected hosts, whereas others can be found in many different plants, such as V. album [27].

2. The European Mistletoe

Viscum album L., commonly known as the European mistletoe, is the most well-known and studied mistletoe species (Figure 1). It is present across the globe, mainly in the Northern Hemisphere, but very rarely in China and Australia [28]. It is historically related to Europe, where the very similar oak mistletoe, Loranthus europaeus Jacq., is also commonly seen. Loranthus europaeus can be differentiated from Viscum album as it is characterized by yellow berries, rather than white (Figure 2) [29,30]. This species should not be confused with V. album, as it has a very different chemical composition, as is well demonstrated by HPTLC analysis [31].
Due to specific and unique characteristics, the European mistletoe has always attracted the attention of humans, who have tended to attribute magical, beneficial, auspicious, and healing powers to this plant.
The berries are certainly the most distinctive and representative part of the European mistletoe because they are white (as evidenced by the epithet “album”) and very ostentatious, unlike the flowers, as evidenced in Figure 3. They are considered the most dangerous part of the whole plant, especially if ingested by mistake; however, this event is quite rare (as judged by related reports) [32]. Originating in the late Middle Ages, a period of obscurantism and prevention began, which had its main fulcrum in the toxicity of berries. Therefore, the use of mistletoe extract has fluctuated between ostracism from its use as an official medicine and the continued use in traditional medicines in all countries where the plant is present [33,34].
After a long period of discouragement of the use of mistletoe to avoid its toxic effects, a change occurred, characterized by the use of hydroalcoholic extracts in anthroposophic medicine to treat cancer [35,36]. This utilization continued uninterrupted and increasingly, mainly in Germany and Switzerland. Although many studies have clarified the mechanism of action, which allows mistletoe to cause selective cell cycle arrest in tumor cells, there are still many doubts about the ability of mistletoe extracts to fight cancer, as questioned by many authors. Meanwhile, the attention of clinicians has shifted to the collateral and complementary effects, both in support of the drug and against the impact of conventional treatments. The clinical trials reported immunoadjuvant, antioxidant, and anti-inflammatory properties [37], including the utilization of the extracts to improve the quality of life of the treated subjects [38]. In this scenario, the antioxidant activity plays a central role, together with the anti-inflammatory properties [39,40,41,42]. The most reported active constituents are known flavonoids, which are present in alcoholic and aqueous extracts [43,44] and are already reported for their anti-ROS and radical-scavengers properties [45], with attention to the variation of the phenolic content in relation to the host [46,47] and the investigated subspecies [48,49,50,51,52,53,54]. Several studies amplified the research to other constituents to evidence how they may cooperate with the activity. Among the constituents of V. album, in addition to microproteins, like viscoproteins and viscolectines [55,56], other constituents have been considered responsible for the activity [57,58,59,60,61,62].
Following the phytocomplex approach, in several papers, more research is considered [63] on the connection made between oxidative stress, inflammation, and many related pathologies [64], in particular, the hypoglycemic effects [65,66]. The antioxidant activity of Viscum extracts has been associated with hypoglycaemia, considering the important role played by oxidative stress in tissue damage by hypoglycaemia and diabetes [67,68,69,70,71], which may be the result of the deterioration in glucose homeostasis caused by metabolic disorders.
This is also in accordance with the possible utilization of Viscum sp. in anti-obesity products and other uses as a potential food and dietary supplement in the nutraceuticals market, which can be associated with the properties of ANFs, the ANtinutritional Factors. ANFs are substances of plant origin, which are considered to be able to reduce the absorption of nutrients, with effects on gastrointestinal function and some metabolic processes [72]. However, there are concerns about the utilization of ANFs, including lectins, saponins, and natural antioxidants, like phytic acid [73]. The negative effects could be reduced or eliminated by preliminary treatments, like fermentation and soaking, as already adopted in the utilization of several foods. It is noteworthy that most of the hydroalcoholic extracts currently used are already subjected to fermentation procedures, although they are administered by intradermal injection. Despite these concerns, the EMA (former EMEA) [74], as well as the US National Cancer Institute, have reported an absence of toxic or severe effects for the oral use of Viscum extracts [75].

3. The Asian Mistletoes

Korean mistletoe is the subspecies coloratum of V. album. It is commonly known as Korean mistletoe because of its wide distribution in many Asian countries, where almost all of its constituent parts are used in folk medicines. In particular, it is present in Ayurvedic and Chinese traditional medicines to treat many diseases, including inflammation, bone fractures, joint pains, arthritis, and hypertension [76]. It is adopted in the Pharmacopoeia of the People’s Republic of China. It can also be called V. articulatum Burn. f., and presents under many synonymous names, such as V. aphyllum Griff., V. attenuatum DC, V, compressum Poir, and others; it has also been identified as Aspidixia articulata (Burm. fil.) van Tiegh [13,77]. This is only one of the numerous related subspecies and varieties of V. album, spread across the planet and present in several tropical hosts, like the cultivated plants of cocoa, coffee, guava, rubber trees, and many others. Research into Asian mistletoes is limited in comparison with European mistletoe [21] but Korean mistletoe is quite an exception since it has been the object of several papers, reporting positive effects in cases of hypertension, ulcers, epilepsy, inflammation, wounds, and nephrotic disease [78]. Major evidence strongly suggests immunostimulant, anti-inflammatory, and antibacterial activity, confirming the properties already reported for the European mistletoe [79,80]. Among the confirmed activities was its antioxidant ability [81], which was associated with an incremental increase in the contents of caffeic acid and lyoniresinol [82]. The future utilization of Viscum extracts in nutraceuticals is also supported by recent research on the positive effects of Korean mistletoe on muscle performance, also in the elderly, including randomized trials [83,84,85,86,87,88]. The attention of Eastern researchers to the utilization of Korean mistletoe for food supplements cannot be considered insignificant since the functional foods originate in Asian countries, named in Japan as Foods for Specified Health Use (FOSHU), and now are present in many countries.
A potent antioxidant property has been reported for different extracts and bioactive constituents of this species. The antioxidant activity of the extracts was attributed to the presence of polyphenols, such as flavonoids and other phenols [89,90], also in consideration of their documented antioxidant activities [91]. Radical scavenging in vitro and in vivo properties of the ethanolic extract of the whole plant was attributed to the phenolic and triterpenes constituents, i.e., oleanolic acid and lupeol, as reported in Table 1. Several studies testify to the absence of toxicity and serious adverse effects. Among the constituents indicated as being responsible for the numerous activities, in addition to the known compounds, including oleanoic acid, betulinic acid, naringenin, and β-amyrin acetate, the compounds named visartisides merit special attention (Figure 4) [90,92,93].
Visartisides A-F are molecules with interesting structures based on a disaccharide nucleus linked to two aromatic units, one of phenylpropanoid type and one C6-C1, joined with an ester and an ether link, respectively. Some visartisides showed relevant anti-inflammatory and antioxidant activity [94,95]. They can inhibit NO production by macrophages, with an effect superior to that recorded for quercetin, which was used as a positive control. The same activity was shown for the ethanol extract of the whole plant when used against human erythrocytes, through stabilization of the cell membrane, with a maximum protection of 68% against haemolysis in comparison with a value of 72% for indomethacin, using a control standard. Although the plant contains flavonoids and polyphenols in good quantity, it is noteworthy that visartisides do not have phenolic groups or triterpene structure. Visartisides were also identified in the metabolome of Romanian V. album in a total of 140 metabolites pertaining to 15 secondary metabolite categories [96]. The identification of antioxidant agents present in plants affords an effective strategy to inhibit pathogenic processes resulting from exposure to numerous degradative syndromes, which are related to oxidative stress and DNA damage by ROS and RNS. Oxidative damage plays a significant role in many human pathologies, including mutagenesis, cancer, and aging, among others [97,98]. Therefore, constituents such as visartisides offer the possibility of obtaining a novel class of antioxidant compounds, although further studies concerning the mechanisms of action are necessary. In addition to V. articulatum, V. liquidambaricolum Hayata, another native Chinese mistletoe that is parasitic on Pyrus, was investigated for its antioxidant activity. Previous phytochemical investigations reported the presence of phenolic glycosides, flavanone glycosides, triterpenoids, organic acids, and flavonoids as the major secondary metabolites [99].
Among the Asian mistletoes, Viscum monoicum Roxb. ex DC. (syn. V. heyneamum DC.) merits a special mention. This species is present in several Asiatic countries, i.e., China and India, where it is utilized in traditional medicines to treat many ailments, i.e., pains, neuropharmacological disorders, and cancers. The analyses revealed relevant antioxidant and anti-inflammatory activities, which were assigned to polyphenolics and flavonoid constituents [100]. Another Indian mistletoe corresponds to Dendrophthoe falcata (L.f.) Ettingsh (syn. Loranthus longifluorous) (Loranthaceae) and is one of the most parasitic widespread plants in the deciduous forests of Western India. It contains flavonoids, triterpenes, and oleic acid. This species, together with D. pentandra (L.) Miq., has been used in the ethnomedicinal systems of India and Indonesia for the treatment of various ailments, including ulcers, asthma, paralysis, skin diseases, tuberculosis, and menstrual pain. D. falcata has been studied for its antimicrobial activity [101,102]. A review of 2023 reports shows studies on several properties, including the antioxidant effects through the inhibition of lipid peroxidation [103].

4. The American Mistletoes

In the southern states of the USA and Mexico, American mistletoe is found, also known as eastern mistletoe and hairy mistletoe. It is similar to the European mistletoe regarding the shape and fruits and corresponds to the species Phoradendron leucarpum (Raf.) Reveal & M.C. Jonst (Santalaceae, previously reported as P. flavescens and P. serotinum, and also transcripted as P. leucoparcum), and is present also as the subspecies tomentosum, named the hairy mistletoe. As European mistletoe, this species was considered toxic in the past, as it is associated with the presence of phoratoxin, which causes vasoconstriction. The toxicity may be the basis of its purported uses, however, it is also a concern for the medicinal use of Viscum sp. The concern was that high doses could induce delirium, hallucinations, bradycardia, hypertension, and cardiac arrest [104]. However, few reports of serious complications from accidental ingestion can be found, and adequate studies have instead demonstrated the contrary for the oral extract in several forms, which are purported to be beneficial for hypotension and constipation. Currently, in the scientific literature, after the pharmacological check, this species is considered free of serious negative or toxic effects [105,106]. This declaration of the safety of the American mistletoe is desirable to promote further study into the biological properties of this important species.
Among the Chilean mistletoes, Tristerix tetrandus (R. et Pav.) Barlow et Wiens (Loranthaceae) is traditionally used as an anxiolytic, anti-inflammatory, digestive, haemostatic, and hypocholesterolemic remedy. Its relevant antioxidant activity was reported and validated by the DPPH antiradical activity assay, the superoxide anion inhibition assay, and the ferric reducing activity, measured as micromoles of Trolox, as standard. The metabolome analysis was performed by UHPLC/MS-MS, evidencing the relevant presence of glycosidic anthocyanins and other flavonoids [107]. The Argentinian mistletoe, Ligaria cuneifolia (R. et P.) Tiegh. (Loranthaceae), is found in Chile, Peru and Argentina and is used in folk medicines. This plant is quite different from other mistletoes because of the evident, red, six, long-petaled with yellow-coloured fruits. Several studies have been performed on this species, reporting anti-hypertensive and anti-cholesterolemic actions, together with antioxidant and immunomodulatory properties [108]. The antioxidant activity of this plant was investigated in connection with the flavonoid-rich fraction [109]. The ex vivo and in vivo tests evidenced an encouraging inhibition of phospholipid oxidation and radical damage. Similar data are reported for Phoradendron liga (Gillies ex Hook. & Arn.) Eichler (Santalaceae), another Argentinian mistletoe which grows mainly in Bolivia and Brazil, in addition to North Argentina, preferably in dry tropical regions. It is noteworthy that triterpene betulin was detected as the active molecule responsible for the inhibition of the P-glycoprotein function in leukaemia cells, evidencing how it is necessary to investigate the active constituents of mistletoe plants [110,111].

5. The African Mistletoes

Mistletoes, in particular those from the genus Viscum, are largely present in Africa. However, these plants were poorly studied, albeit there are very interesting examples of variation and adaptation, including species parasitizing succulent plants, mainly present in Southern regions. The V. minimum Harv. is a very small mistletoe that lives inside the stem of the columnar great Euphorbiaceae. V. minimum has no leaves, roots or stems and lives inside the succulent cactus body of the host [112]. In this way, the plant can survive drought and remain protected. It is visible only during reproduction when the small flowers and fruits emerge. Another example is V. crassula Eckl. & Zeyh, which is a succulent mistletoe specialized in parasitizing Portulaca afra, another succulent species (Didieraceae), which is one of the favourite foods of elephants.
V. rotundifolium L. f. is a red-berry mistletoe, mainly present in southern Africa and able to survive in the Kalahari Desert [113]. The antioxidant and antibacterial activity of this hemiparasite was investigated together with its host, Mystroxylon aethiopicum (Thumb.) Loes subsp. schlechteri (Loes.) R.H. Archer (Celastraceae), commonly known as bushveld kooboob berry. The simplified phytochemical tests evidenced a similar chemical composition for the most common secondary metabolites, as well as the absence of relevant differences in the extracts with different solvents from the two species. Finally, it was possible to determine the absence of toxicity to human cells and the safety of the plant extracts [114,115].
The antioxidant activity of the investigated mistletoe species is reported in Table 1. The reported data in Table 1 merits some additional consideration concerning the methods. There is a large range of available tests for examining antioxidant activity, i.e., ORAC, HORAC, TRAP, TOSC, CUPRAC, FRAP, ABTs, and DPPH tests [116]. Several papers on the antioxidant and enzyme activity effects of Viscum extracts are based on a variety of tests. The DPPH assay is the most used due to its ease, but, in many cases, further testing is required to obtain more information about the type of activity and the mechanism of action. If a plant extract is subjected to ordinary antioxidant tests, the novelty should be the absence of activity. Plant metabolism usually involves an abundance of phenols, whose radical scavenger and anti-ROS properties are well known. However, phenol functions can be found in several classes of natural products with very different structures, from monocycle hydroquinones to polymeric tannins; other molecules cannot be excluded. Similar considerations can be presented for chemical analyses, which are used to provide evidence for the chemistry of the active constituents. The colorimetric Folin-Ciocalteu reagent is often employed to measure the number of phenolic compounds. However, this method could lead to erroneous results due to an overestimation of the true phenolic level in the analysed reagent, since the reagent reacts with all the oxidants present. Analogous consideration for the Dragendorff reagent, commonly used for the detection of alkaloids, which can react in the presence of compounds with an alpha, beta-unsaturated ketone group, such as in several phytosteroids.
Therefore, considering these factors, the argument must focus on the effectiveness and the mechanism of action. In the literature regarding the antioxidant activity of the European mistletoe, there are publications with such simplified tests, mainly focused on ethnobotanical studies [117,118,119], but most of the contributions are interested in connecting the activity with the mechanism or with other properties, including the study of the constituents responsible of the biological properties.

6. Conclusions

Table 1 contains the species discussed in this review, including the common names, the antioxidant studies, and the related references. It is evident that so far, the studies were influenced by the prevalent presence of European mistletoe and its utilization in complementary treatments in oncology [120,121,122], though there is an abundance of research focused on antioxidant activities. Southern African countries are a potential source of native, undiscovered, exceptional species [123]. The results of the metabolomic analyses, based on new, advanced analytical methods, are changing the previous information based on classic phytochemical methods [97,105,124] and evidence of the variation of the metabolome concerning the host and the harvest period [125]. In addition, the study of the interactions with protein networks is in progress due to in silico analyses [126]. In particular, the proteomic study provides evidence of many special microProteins, in addition to viscolectins and viscotoxins, with antioxidant activity [54,92,127,128,129,130,131]. Finally, this paper suggests that the chemical and pharmacologic value of mistletoes is only just being realised, and further research may reveal more interesting properties and other species to be investigated [132].
Concerning the future of mistletoe in medicine, the utilization of mistletoe extracts is increasing, in particular in oncology treatment, albeit always under discussion [133] and in consideration of the complementary effects, such as the antioxidant and immunostimulation properties [134]. However, the use of these extracts is also related to many other medical products, which are increasing their relevance in the market, like the utilization in homeopathy [135], nutraceuticals [136] meristemotherapy [31,137], and veterinary treatment [138,139].

Funding

This review received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created.

Conflicts of Interest

The author declares no personal circumstances that may be perceived as inappropriately influencing the representation or interpretation of the reported considerations.

Abbreviations

AETsAerobic Thresholds
AzBTS-(NH4)22,2′-amino-di-[3-ethylbenzthiazoline sulfonate]
CATCatalase
CUPRACCupric Reducing Antioxidant Power
DRSADose-response Surface Assay
EMAEuropean Medicines Agency
EMEAEuropean Medicines Evaluation Agency
FRAPFerric Reducing Antioxidant Power
GHS-PxGlutathione peroxidase
GRGlutathione reductase
GSTGlutathione-S-transferase
HORACHydroxyl Radical Antioxidant Capacity
HPSAHydrogen Peroxide Scavenging Activity
ORACOxygen Radical Absorption Capacity
DPPHDiphenyl-1-picrylhydrazyl
RNSReactive Nitrogen Species
ROSRadical Oxygen Species
SASuperoxide anion scavenging activity
SODSuperoxide dismutase
TEACTrolox Equivalent Antioxidant Capacity
TOSCTotal Oxyradical Scavenging Capacity
TPCTotal Phenolic Content
TRAPTotal Peroxyl Radical Trapping Antioxidant Parameter

References

  1. Büssing, A. History of mistletoe uses. In Mistletoe. The Genus Viscum; Büssing, A., Ed.; Harwood Academic Publishers: Amsterdam, The Netherlands, 2000; pp. 1–6. [Google Scholar]
  2. Kienle, G.S.; Kiene, H. Complementary cancer therapy: A systematic review of prospective clinical trials on anthroposophic mistletoe extracts. Eur. J. Med. Res. 2007, 12, 103–119. [Google Scholar] [PubMed]
  3. Ostermann, T.; Appelbaum, S.; Poier, D.; Boehm, K.; Raak, C.; Bussing, A. A Systematic Review and Meta-Analysis on the Survival of Cancer Patients Treated with a Fermented Viscum album L. Extract (Iscador): An Update of Findings. Complement. Med. Res. 2020, 27, 260–271. [Google Scholar] [CrossRef] [PubMed]
  4. Onay-Ucar, E.; Ozlem, E.; Kandemir, B.; Mertoglu, E.; Kamdemir, B.; Mertoglu, E.; Karagoz, A.; Arda, N. Viscum album L. Extracts Protects HeLa Cells against Nuclear and Mitochondrial Damage. Evid. Based Complement. Altern. Med. 2012, 2012, 958740. [Google Scholar] [CrossRef] [Green Version]
  5. Braedel-Ruoff, S. Immunomodulatory effects of Viscum album extracts on natural killer cells: Review of clinical trials. Complement. Med. Res. 2010, 17, 63–73. [Google Scholar] [CrossRef]
  6. Gardin, N.E. Immunological response to mistletoe (Viscum album L.) in cancer patients: A four-case series. Phytother. Res. 2009, 23, 407–411. [Google Scholar] [CrossRef] [PubMed]
  7. Schad, F.; Thronicke, A. Safety of Combined Targeted and Helixor® Viscum album L. Therapy in Breast and Gynecological Cancer Patients, a Real-World Data Study. Int. J. Environ. Res. Public Health 2023, 20, 2565. [Google Scholar] [CrossRef] [PubMed]
  8. Crimeen-Irwin, B.; Scalzo, K.; Gloster, S.; Mottram, P.L.; Plebansky, M. Failure of immune homeostasis—The consequences of under and over reactivity. Curr. Drug Targets-Immune Endocr. Metab. Disord. 2005, 5, 413–422. [Google Scholar] [CrossRef]
  9. Sayed, N.; Huang, Y.; Nguyen, K.; Krejciova-Rajajaneemi, Z.; Grave, A.P.; Gao, T.; Tibshirani, R.; Astie, T.; Alpet, A.; Cui, L.; et al. An Inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging. Nat. Aging 2021, 1, 568–615. [Google Scholar]
  10. Pontes Oliveira de Almeida, A.J.; de Almeida Rezende, M.S.; Dantas, S.M.; de Lima Siva, S.; de Oliveira, J.C.P.L.; de Azevedo, F.d.L.A.A.; Alves, R.M.F.R.; de Menezes, G.M.S.; dos Santos, P.F.; Gonçalves, T.A.F.; et al. Unveiling the Role of Inflammation and Oxidative stress on Age-Related Cardiovascular Diseases. Oxidative Med. Cell. Longev. 2020, 2020, 1954398. [Google Scholar]
  11. Arulselvan, P.; Fard, M.T.; Tan, W.S.; Gotha, S.; Fawurazi, S.; Norheizan, M.E. Role of Antioxidants and Natural Products in Inflammation. Oxidative Med. Cell. Longev. 2016, 2016, 5276130. [Google Scholar] [CrossRef] [Green Version]
  12. Dančík, V.; Petri Seiler, K.; Young, D.W.; Schreiber, S.L.; Paul, A.; Clemons, P.A. Distinct Biological Network Properties between the Targets of Natural Products and Disease Genes. J. Am. Chem. Soc. 2010, 132, 9259–9261. [Google Scholar] [CrossRef]
  13. Nicoletti, M. The anti-inflammatory activity of Viscum album. Plants 2023, 12, 1460. [Google Scholar] [CrossRef]
  14. Fineren, B.A. Root Parasitism in Santalaceae. Nature 1963, 197, 65. [Google Scholar] [CrossRef]
  15. Nickrent, D.L.; Valéry Malécot, V.; Vidal-Russell, R.; Der, J.P. A revised classification of Santalales. Taxon 2010, 59, 538–558. [Google Scholar] [CrossRef]
  16. Maclean, A.E.; Hertle, A.P.; Ligas, O.; Bock, R.; Balk, J.; Meyer, E.H. Absence of complex I is associated with diminished respiratory chain function in European mistletoe. Curr. Biol. 2018, 28, 1614–1619. [Google Scholar] [CrossRef] [Green Version]
  17. Hudák, J.; Lux, A. Chloroplast ultrastructure of semiparasitic Viscum album L. Photosynthetica 1986, 20, 223–224. [Google Scholar]
  18. Senkler, J.; Rugen, N.; Eubel, H.; Hegermann, J.; Braun, H.P. Absence of Complex I Implicates Rearrangement of the Respiratory Chain in European Mistletoe. Curr. Biol. 2018, 28, 1606–1613. [Google Scholar] [CrossRef] [Green Version]
  19. Lucie Schröder, L.; Hohnjec, N.; Senkler, M.; Senkler, J.; Küster, H.; Braun, H.-P. The gene space of European mistletoe (Viscum album). Plant J. 2022, 109, 278–294. [Google Scholar] [CrossRef]
  20. Schroder, L.; Hegermann, J.; Pille, P. The Photosynthesis Apparatus of European mistletoe (Viscum album). Plant Physiol. 2022, 190, 1869–1914. [Google Scholar] [CrossRef]
  21. Skippington, E.; Barkman, T.J.; Rice, D.W.; Palmer, J.D. Comparative mitogenomics indicates respiratory competence in parasitic Viscum despite loss of complex I and extreme sequence divergence, and reveals horizontal gene transfer and remarkable variation in genome size. BMC Plant Biol. 2017, 17, 49. [Google Scholar] [CrossRef] [Green Version]
  22. De Olivéira Melo, M.N.; da Costa Batista, J.V.; Penazola, E.M.C.; Oliveira, A.P.; Garrett, R.; Baumgertner, S.; Holandino, C. A Scoping Review of Genus Viscum: Biological and Chemical Aspects of Alcoholic Extracts. Plants 2023, 12, 1811. [Google Scholar] [CrossRef] [PubMed]
  23. Christenhusz, M.J.M.; Fay, M.F.; Chase, M.W. Plants of the World; Kew Publishing Royal Botanical Kew: Richmond, UK; The University of Chicago Press: Chicago, IL, USA, 2017; pp. 426–427. [Google Scholar]
  24. Büssing, A. (Ed.) Mistletoe, The Genus Viscum (Medicinal and Aromatic Plants-Industrial Profiles); Harwood Academic Publishers, CRC: Amsterdam, The Netherlands, 2000. [Google Scholar]
  25. WFO. Viscum L. 2023. Available online: http://worldfloraonline.org/taxon/info-40000403344 (accessed on 19 July 2023).
  26. Krasylenko, J.; Tesitel, J.; Ceccantini, G.; Oliveira-da-Silva, M.; Dvořák, V.; Steele, D.; Sosnovsky, Y.; Piwowarczyk, R.; Watson, D.M.; Teixeira-Costa, L. Parasites on Parasites: Hyper-, epi-, autoparasitism among flowering plants. Am. J. Bot. 2021, 108, 8–21. [Google Scholar] [CrossRef] [PubMed]
  27. Ture, C.; Bocuk, H.; Asan, Z. Nutritional relationships between hemiparasitic mistletoe and some of its deciduous hosts in different habitats. Biologia 2010, 65, 859–867. [Google Scholar] [CrossRef]
  28. Ramm, H.; Urech, K.; Scheibler, M.; Grazi, G. Cultivation and development of Viscum album. In Mistletoe: The Genus Viscum; Bussing, A., Ed.; Harwood Academic Publishers: Reading, UK, 2000. [Google Scholar]
  29. Barney, C.W.; Hansksworth, F.G.; Geils, B.W. Hosts of Viscum album. Eur. J. For. Pathol. 1998, 28, 187–208. [Google Scholar] [CrossRef]
  30. Krasylenko, Y.; Gleb, R.H.; Volutsa, O. Loranthus europaeus (Loranthaceae) in Ukraine. Ukranian Bot. J. 2019, 76, 406–417. [Google Scholar] [CrossRef] [Green Version]
  31. Piterà, F.; Nicoletti, M. Gemmoterapia. Fondamenti Scientifici Della Moderna Meristemoterapia, 2nd ed.; Nuova Ipsa Editore: Palermo, Italy, 2018; pp. 642–649. [Google Scholar]
  32. Strader, D.B.; Navarro, V.J.; Seeff, L.B. Chapter 26—Hepatotoxicity of Herbal Preparations. In Zakim and Boyer’s Hepatology, 6th ed.; Boyer, T.D., Manns, M.P., Sanyal, A.J., Eds.; Saunders W.B.: Philadelphia, PA, USA; Elsevier: London, UK, 2012; pp. 462–475. [Google Scholar]
  33. Ramm, H. Mistletoe through Cultural and Medical History: The All-Healing Plant Proves to Be a Cancer-Specific Remedy. In Mistletoe: From Mythology to Evidence-Based Medicine; Zänker, K.S., Kaveri, S.V., Eds.; Translational Research in Biomedicine; Karger Publishers: Basel, Switzerland, 2015; volume 4, pp. 1–10. [Google Scholar]
  34. Monti, M. Mistletoe-From Mythology to Evidenced-Based Medicine. Eur. J. Histochem. 2015, 59, 2577. [Google Scholar] [CrossRef] [Green Version]
  35. Kiele, G.; Albonico, H.-L.; Baars, E.; Hamre, H.J.; Zimmermann, P.; Kiene, H. Anthroposophic Medicine: An Integrative Medical System Originating in Europe. Glob. Adv. Health Med. 2013, 2, 20–31. [Google Scholar]
  36. Kienle, G.S.; Kiene, H.; Albonico, H.U. Anthroposophic Medicine: Effectiveness, Utility, Costs, Safety; Schattauer Verlag: Stuttgart, Germany; New York, NY, USA, 2006. [Google Scholar]
  37. Singh, B.N.; Saha, C.; Galun, D.; Upreti, D.K.; Bayry, J.; Kavery, S.V. European Viscum album: A potent phytotherapic agent with multifarious phytochemical properties and clinical evidence. RSC Adv. 2016, 6, 23837–23857. [Google Scholar] [CrossRef] [Green Version]
  38. Freuding, M.; Keinki, C.; Kutschan, S.; Buentzel, J.; Huebner, J. Mistletoe in oncological treatment: A systematic review: Part 1 survival and safety and Part 2: Quality of life and toxicity of cancer treatment. J. Cancer Res. Clin. Oncol. 2019, 145, 695–707. [Google Scholar] [CrossRef]
  39. Tepe Diek, H.; Ugururlu, A.; Yazgan, I. Determination of Phenolic Compounds, Organic Volatile Molecules and Anti-Cancer Properties in Inula viscosa L., Viscum album L. and Raphanus sativus L. Sak. Univ. J. Sci. 2021, 25, 647–662. [Google Scholar] [CrossRef]
  40. Kusi, M.; Shrestha, K.; Malia, R. Study on Phytochemical, Antibacterial, Antioxidant and Toxicity Profile of Viscum album Linn Associated with Acacia catechu. Nepal J. Biotechnol. 2015, 3, 60–65. [Google Scholar] [CrossRef] [Green Version]
  41. Alpsoy, L.; Uzonur, I.; Sakcali, M.S.; Karaman, S. Antioxidant and Antimutagenic Activities of Viscum album Fruit Ethanolic Extract in Human Lymphocytes. Afr. J. Biotechnol. 2010, 9, 2539–2543. [Google Scholar]
  42. Pieme, C.A.; Ngogang, J.; Costache, M. In Vitro Antiproliferative and Antioxidant Activities of Methanol Extracts of Urena lobate and Viscum album against Breast Cancer Cell Lines. Toxicol. Environ. Chem. 2012, 94, 987–999. [Google Scholar] [CrossRef]
  43. Anatole, P.C.; Jeanne, N.; Marieta, C. Polyphenol Contents of Five of Medicinal Plants from Cameroon and Effects of Their Extracts on Antioxidant Capacities of Human Breast Cancer Cells. Toxicol. Environ. Chem. 2014, 96, 1120–1130. [Google Scholar]
  44. Sárpataki, O.; Sevastre, B.; Stan, R.; Olah, N.H.; Hanganu, D.; Bedeceau, I.; Ionescu, C.; Marcus, I. Viscum album L. Influence on the Antioxidant Enzymes Activity in Ehrlich Tumor Cells In Vivo. Bull. UASVM Vet. Med. 2014, 71, 198–203. [Google Scholar]
  45. Elleru, S.R.; Maddur, M.S.; Friboulet, A.; Bayry, J.; Kaveri, S.V. Dissecting the Anti-Inflammatory Effects of Viscum album: Inhibition of Cytokine-Induced Expression of Cyclo-Oxygenase-2 and Secretion of Prostaglandin E2. In Mistletoe: From Mythology to Evidence-Based Medicine; Zänker, K.S., Kaveri, S.V., Eds.; Translational Research in Biomedicine; Karger Publishers: Basel, Switzerland, 2015; volume 4, pp. 67–73. [Google Scholar]
  46. Hedge, P.; Maddur, M.S.; Friboulet, A.; Bayry, J.; Kavery, S. Viscum album exerts anti-inflammatory effect by selectively inhibiting cytokine-induced expression of cyclooxygenase-2. PLoS ONE 2011, 6, e26312. [Google Scholar]
  47. Pietrzak, W.; Nowak, R.; Olech, M. Effect of extraction method on phenolic content and antioxidant activity of mistletoe extracts from Viscum album subsp. abietis. Chem. Pap. 2014, 68, 976–982. [Google Scholar] [CrossRef]
  48. Papuc, C.; Crivineanu, M.; Goran, G.; Nicorescu, V.; Durdun, N. Free Radicals Scavenging and Antioxidant Activity of European Mistletoe (Viscum album) and European Birthwort (Aristolochia clematitis). Rev. Chim. 2010, 61, 619–622. [Google Scholar]
  49. Speisky, H.; Shahidi, F.; de Camargo, A.C.; Fuentes, J. Revisiting the Oxidation of Flavonoids: Loss, Conservation or Enhancement of Their Antioxidant Properties. Molecules 2022, 11, 133. [Google Scholar] [CrossRef]
  50. Becker, H.; Exner, J. Comparative Studies of Flavonoids and Phenylcarboxylic Acids of Mistletoes from Different Host Trees. Z. Pflanzenphysiol. 1980, 97, 417–428. [Google Scholar] [CrossRef]
  51. Skrypnik, L.; Maslennikov, P.; Feduraev, P.; Pungin, A.; Belov, N. Changes in Antioxidative Compounds and Enzymes in Small-Leaved Linden (Tilia cordata Mill.) in Response to Mistletoe (Viscum album L.) Infestation. Plants 2021, 10, 1871. [Google Scholar] [CrossRef]
  52. Panossian, A.; Kocharian, A.; Matinian, K.; Amroyanm, E.; Gabrelian, E.; Mayr, C.; Wagner, H. Pharmacological activity of phenylpropanoids of the mistletoe, Viscum album L., host: Pyrus caucasica fed. Phytomedicine 1998, 5, 11–17. [Google Scholar] [CrossRef]
  53. Kleszken, E.; Purcarea, C.; Pallag, A.; Ranga, F.; Memete, A.R.; Miere, F.; Vicas, S.I. Phytochemical Profile and Antioxidant Capacity of Viscum album L. Subsp. album and Effects on Its Host Trees. Plants 2022, 11, 3021. [Google Scholar] [CrossRef] [PubMed]
  54. Onay-Uçar, E.; Karagoz, A.; Arda, N. Anti-oxidant activity of Viscum album ssp. album. Fitoterapia 2006, 77, 556–560. [Google Scholar] [CrossRef] [PubMed]
  55. Yousefvand, S.Y.; Fathahi, F.; Hosseini, S.M.M.; Urech, K.; Schaller, G. Viscotoxin and lectin content in foliage and fruits of Viscum album L. on the main host trees of Hycanian forests. Sci. Rep. 2002, 12, 10383. [Google Scholar] [CrossRef] [PubMed]
  56. Elsasser-Beile, U.; Voss, M.; Schule, R.; Wetterauer, U. Biological effects of natural and recombinant mistletoe lectin and an aqueous mistletoe extract on human monocytes and lymphocytes in vitro. J. Clin. Lab. Anal. 2000, 14, 255–259. [Google Scholar] [CrossRef]
  57. Sengul, M.; Yildiz, H.; Gungor, N.; Cetin, B.; Eser, Z.; Erasli, S. Total phenolic content, antioxidant and antimicrobial activities of some medicinal plants. Pak. J. Pharm. Sci. 2009, 22, 102–106. [Google Scholar]
  58. Nhiem, N.X.; Kiem, P.V.; Minh, C.V.; Kim, N.; Park, S.; Lee, H.Y.; Kim, E.S.; Kim, J.H.; Kim, S.; Koh, J.-S.; et al. Diarylheptanoids and flavonoids from Viscum album inhibit LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells. J. Nat. Prod. 2013, 76, 495–502. [Google Scholar] [CrossRef]
  59. Dai, J.K.; Cao, D.; Li, C.-H. Three new bioactive flavonoids glycosides from Viscum album. Chin. J. Nat. Med. 2019, 17, 545–550. [Google Scholar] [CrossRef]
  60. Orhan, D.D.; Calis, I.; Ergun, F. Two New Flavonoid Glycosides from Viscum album spp. album. Pharm. Biol. 2002, 40, 380–383. [Google Scholar] [CrossRef]
  61. Orhan, D.D.; Senol, F.S.; Hosbas, S.; Orhan, I.E. Assessment of cholinesterase and tyrosinase inhibitory and antioxidant properties of Viscum album L. samples collected from different host plants and its two principal substances. Ind. Crops Prod. 2014, 62, 341–349. [Google Scholar] [CrossRef]
  62. Wójciak-Kosior, M.; Sowa, I.; Pucek, K.; Szymczak, G.; Kocjan, R.; Luchowsli, P. Evaluation of seasonal changes of triterpenic acid contents in Viscum album from different host trees. Pharm. Biol. 2017, 55, 1–4. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Popova, O.I. Phenolic compounds of Viscum album. Chem. Nat. Compd. 1991, 27, 123. [Google Scholar] [CrossRef]
  64. Delebinski, C.I.; Twardziok, M.; Kleinsimon, S.; Hoff, F.; Mulsow, K.; Rolff, J.; Jaser, S.; Eggert, A.; Seifert, G. (A Natural Combination Extract of Viscum album L. Containing Both Triterpene Acids and Lectins Is Highly Effective against AML In Vivo. PLoS ONE 2015, 10, e0133892. [Google Scholar] [CrossRef]
  65. Oremosu, A.; Edem, E.E.; Dosumu, O.O.; Osuntoki, A.A. African mistletoe (Loranthaceae) ameliorates cholesterol-induced motor deficit and oxidative stress in adult BALB/c mice. J. Exp. Clin. Anat. 2017, 16, 121–131. [Google Scholar]
  66. Orhan, D.D.; Aslan, M.; Sendogdu, N.; Ergun, F.; Yesilada, E. Evaluation of the hypoglycemic effect and antioxidant activity of three Viscum album subspecies (European mistletoe) in streptozotocin-diabetic rats. J. Ethnopharmacol. 2005, 98, 95–102. [Google Scholar] [CrossRef]
  67. Bhardwaj, S.K.; Sharma, M.L.; Gulati, G.; Chhabra, A.; Kaushik, R.; Sharma, P.; Kaur, G. Effect of starvation and insulin-induced hypoglycemia on oxidative stress scavenger system and electron transport chain complexes from rat brain, liver, and kidney. Mol. Chem. Neuropathol. 1998, 34, 157–168. [Google Scholar] [CrossRef]
  68. Shahaboddin, M.E.; Pouramir, M.; Moghadamnia, A.A.; Lakzaei, M.; Mirhashemi, S.M.; Mdaballabi, M. Antihyperglycemic and antioxidant activity of Viscum album extract. Afr. J. Pharm. Pharmacol. 2011, 5, 432–436. [Google Scholar] [CrossRef]
  69. Yousefi, M.; Farsani, M.N.; Ghafarifarsani, H.; Hoseinifar, S.H.; Doan, H.V. Effect of dietary supplements of mistletoe (Viscum album) extract on the grow performance, antioxidant, and innate, immune responses of rainbow trout (Oncorhychus mykis). Aquaculture 2021, 536, 736385. [Google Scholar] [CrossRef]
  70. Ullah, M.; Mehmood, S.; Ali Khan, R.; Ali, M.; Fozia, F.; Waqas, M.; Ullah, R.; Alotaibi, A.; Sultan, M.A. Assessment of Antidiabetic Potential and Phytochemical Profiling of Viscum album, a Traditional Antidiabetic. Plant J. Food Qual. 2022, 2022, 5691379. [Google Scholar] [CrossRef]
  71. Singh, P.; Jain, A.; Kaur, G. Impact of hypoglycaemia and diabetes on CNS, correlation of mitochondrial oxidative stress with DNA damage. Mol. Cell. Biochem. 2004, 260, 153–159. [Google Scholar] [CrossRef] [PubMed]
  72. Samtiya, M.; Aluko, R.E.; Dhewa, T. Plant food anti-nutritional factors and their reduction strategies: An overview. Food Prod. Process. Nutr. 2020, 2, 6. [Google Scholar] [CrossRef] [Green Version]
  73. Hamid, R.; Masood, A.; Wani, I.H.; Rafiq, S. Lectins: Proteins with diverse applications. J. Appl. Pharm. Sci. 2013, 3, S93–S103. [Google Scholar]
  74. Committee for Veterinary Medicinal Products. Viscum album, Summary Report; EMEA/MRL/680/99-Final; The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit: Amsterdam, The Netherlands, 1999. [Google Scholar]
  75. National Cancer Institute. Mistletoe Extracts (PDQ®–Health Professional Effects (1.13.2023). Available online: http://www.cancer.gov/about.cancer/treatment/com/patient/mistletoe-pdq (accessed on 21 June 2023).
  76. Hassler, M. World Plants: Synonymic Checklists of the Vascular Plants of the World (Version Nov 2015). In Species 2000 ITIS Catalogue of Life; Roskov, Y., Ower, G., Orrell, T., Nicolson, D., Bailly, N., Kirk, P.M., Bourgoin, T., DeWalt, R.E., Decock, W., van Nieukerken, E., et al., Eds.; Naturalis: Leiden, The Netherlands, 2019. [Google Scholar]
  77. Park, W.B.; Lyu, S.Y.; Kim, J.H.; Choi, S.H.; Chung, H.K.; Ahn, S.H.; Hong, S.Y.; Yoon, T.J.; Choi, M.J. Inhibition of tumor growth and metastasis by Korean mistletoe lectin is associated with apoptosis and antiangiogenesis. Cancer Biother. Radiopharm. 2001, 16, 439–447. [Google Scholar] [CrossRef]
  78. Das, M.K.; Sharma, R.S.; Mishra, V. A cytotoxic type-2 ribosome inactivating protein (from leafless mistletoe) lacking sugar binding activity. Int. J. Biol. Macromol. 2011, 49, 1096–1103. [Google Scholar] [CrossRef]
  79. Wei, X.-Y.; Guo, W.-J.; Chen, Z.-Y.; Qiu, Z.-D.; Guo, J.; Cui, G.-H.; Wang, Y.-N.; Gong, L.; Chen, L.-Y.; Lai, C.-J.-S.; et al. Chemical-activity-based quality marker screening strategy for Viscum articulatum. Biomed. Chromatogr. 2021, 35, 12. [Google Scholar] [CrossRef]
  80. Ha, S.-M.; Kim, J.-M.; Kim, J.-W. The potential Role of Korean Mistletoe as an Anti-inflammatory Supplementation. J. Immunol. Res. 2021, 2021, 2183427. [Google Scholar] [CrossRef]
  81. Garg, S.; Patil, U.K.; Shivastava, T.P. Antimicrobial potential of Viscum articulatum Burn., an ethnomedicinal plant. Res. J. Pharm. Technol. 2013, 6, 649–651. [Google Scholar]
  82. Kim, S.Y.; Yang, E.J.; Son, Y.K.; Yeo, J.H.; Song, K.-S. Enhanced anti-oxidative effect of fermented Korean mistletoe is originated from an increase in the contents of caffeic acid and lyoniresinol. Food Funct. 2016, 7, 2270–2277. [Google Scholar] [CrossRef]
  83. Geetha, K.M.; Bindu, V.; Murugan, V. Antioxidant potential of Viscum articulatum burn. Chron. Joung Sci. 2013, 4, 32. [Google Scholar] [CrossRef]
  84. Li, H.Z.; Hou, Z.; Li, C.; Zhang, Y.; Shen, T.; Hu, Q.W.; Ren, D.M. Three pairs of diastereoisomeric flavanone glycosides from Viscum articulatum. Fitoterapia 2015, 102, 156–162. [Google Scholar] [CrossRef] [PubMed]
  85. Jung, H.-Y.; Kim, Y.-H.; Kim, I.-B.; Jeong, J.S.; Lee, J.-H.; Do, M.-S.; Jung, S.-P.; Kim, K.-S.; Kim, K.-T.; Kim, J.-B. The Korean mistletoe (Viscum album coloratum) extract has an antiobesity effect and protects against hepatic steatosis in mice with high-fat diet-induced obesity. Evid.-Based Complement. Altern. Med. 2013, 2013, 168207. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Jung, H.-Y.; Lee, A.-N.; Song, T.-J.; An, H.-S.; Kim, Y.-H.; Kim, K.-D.; Kim, I.-B.; Kim, K.-S.; Han, B.-S.; Kim, C.-H. Korean mistletoe (Viscum album coloratum) extract improves endurance capacity in mice by stimulating mitochondrial activity. J. Med. Food 2012, 15, 621–628. [Google Scholar] [CrossRef] [PubMed]
  87. Lim, N.J.; Shin, J.H.; Kim, H.J.; Lim, Y.; Kim, J.Y.; Lee, W.J.; Han, S.J.; Kwon, O. A combination of Korean mistletoe extract and resistance exercise retarded the decline in muscle mass and strength in the elderly: A randomized controlled trial. Exp. Gerontol. 2017, 87, 48–56. [Google Scholar] [CrossRef] [PubMed]
  88. Jeong, J.; Park, C.-H.; Kim, I.; Kim, Y.-H.; Yoon, J.-M.; Kim, K.-S.; Kim, J.-B. Korean mistletoe (Viscum album coloratum) extract regulates gene expression related to muscle atrophy and muscle hypertrophy. BMC Complement. Altern. Med. 2017, 17, 68. [Google Scholar] [CrossRef] [Green Version]
  89. Lee, S.-H.; Kim, I.-B.; Kim, J.-B.; Park, D.-H.; Min, K.-J. The effects of Korean mistletoe extract on endurance during exercise in mice. Anim. Cells Syst. 2014, 18, 34–40. [Google Scholar] [CrossRef] [Green Version]
  90. Nag, M.; Kar, A.; Chanda, J.; Mukherjee, P.K. RP-HPLC analysis of methanol extract of Viscum articulatum. J. Ayurveda Integr. Med. 2020, 11, 277–280. [Google Scholar] [CrossRef]
  91. Rice-evans, C.A.; Miller, N.J.; Bolwell, P.G.; Bramley, P.M.; Pridham, J.P. The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic. Res. 1995, 22, 375–383. [Google Scholar] [CrossRef]
  92. Chuan, S.; Xu-Ya, W.; Zi-Dong, Q.; Li, G.; Ze-Yan, C.; Ying, M.; Ye, S.; Yu-Jun, Z.; Wei-hao, W.; Chang-Jiang-Sheng, L.; et al. Exploring the resources of the genus Viscum for potential therapeutic applications. J. Ethnopharmacol. 2021, 277, 114233. [Google Scholar]
  93. Afan, I.N.; Azizah, Z.; Rivai, H. Overview of the Phytochemicals and Medicinal Plants to Lower Blood Pressure. Sch. Acad. Parm. 2020, 9, 318–329. [Google Scholar] [CrossRef]
  94. Kuo, Y.-J.; Yang, Y.-C.; Zhang, L.-J.; Wu, M.-D.; Kuo, L.-M.Y.; Kuo, Y.-C.; Hwang, S.-Y.; Chou, C.-J.; Lee, K.-H.; Ho, H.-O.; et al. Flavanone and Diphenylpropane Glycosides and Glycosidic Acyl Esters from Viscum articulatum. J. Nat. Prod. 2010, 73, 109–114. [Google Scholar] [CrossRef] [PubMed]
  95. Lee, Y.; Zhao, Y.-L.; Yang, N.; Li, X.L. Two New Phenolic Glycosides from Viscum articulatum. Molecules 2008, 13, 2500–2508. [Google Scholar]
  96. Segneanu, A.-E.; Marin, C.N.; Herea, D.D.; Stanusoiu, I.; Minteau, C.; Grozescu, I. Romanian Viscum album L.-Untargeted Low-Molecular Metabolomic Approach to Engineered Viscum-AuNPs Carrier Assembly. Plants 2022, 11, 1820. [Google Scholar] [CrossRef]
  97. Makhafola, T.J.; Elgorashi, E.E.; McGaw, L.J.; Verschaeve, L.; Nicolaas Eloff, N.J. The correlation between antimutagenic activity and total phenolic content of extracts of 31 plant species with high antioxidant activity. BMC Complement. Altern. Med. 2016, 16, 490. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  98. Pizzino, G.; Irrera, N.; Cucinotta, M.; Pullio, G.; Marinino, F.; Arcoraci, Y.; Samadrito, F.; Altavilla, D.; Bitto, A. Oxidative Stress: Harms and Benefits for Human Health. Oxid. Med. Cell. Longev. 2017, 2017, e8416263. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  99. Li, Q.; Yang, S.; Li, Y.; Xue, X.; Huang, Y.; Luo, H.; Zhang, Y.; Lu, Z. Comparative Evaluation of Soluble and Insoluble-Bound Phenolics and Antioxidant Activity of Two Chinese Mistletoes. Molecules 2018, 23, 359. [Google Scholar] [CrossRef] [Green Version]
  100. Ahmed, K.S.; Farzena, M.; Rahaman, S.E.; Jahan, I.A.; Khan, T.A.; Al-Mansur, M.A.; Sultana, N.; Hossein, H. Viscum monoicum: A New Source of Polyphenolic Compounds Responsible for Antioxidant and Anti-inflammatory Activities. J. Herbs Spices Med. Plants 2023. [CrossRef]
  101. Patil, S.H.; Patil, V.S.; Jadhav, R.B.; Talel, G.S.; Surana, S.J. Antimicrobial activity of an Indian mistletoe, the hemiparasite Dendrophthoes falcata L. f. (Loranthaceae). Res. Educ. Indian Med. 2012, 18, 107–111. [Google Scholar]
  102. Kong, D.; Wang, L.; Niu, Y.; Cheng, L.; Song, B.; Wang, D.; Tian, J.; Zhao, W.; Liu, X.; Chen, Y.; et al. Dendrophthoe falcata (L.f.) Ettingsh. and Dendrophthoe pentandra (L.) Miq.: A review of traditional medical uses, phytochemistry, pharmacology, toxicity, and applications. Front. Pharmacol. 2023, 14, 1096379. [Google Scholar] [CrossRef]
  103. Pattanayak, S.P.; Sunita, P. Wound healing, anti-microbial and antioxidant potential of Dendrophthoe falcata (L.f.) Ettingsh. J. Ethnopharmacol. 2008, 120, 241–247. [Google Scholar] [CrossRef]
  104. National Institute of Diabetes and Digestive and Kidney Diseases. Mistletoe, in LiverTox: Clinical and Research Information on Drug-Induced Liver Injury; National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, USA, 2012. Available online: Livertox.nih.gov (accessed on 25 July 2022).
  105. Spiller, H.A.; Williams, D.B.; Gorman, S.E.; Samftleban, J. Retrospective study of mistletoe ingestion. J. Toxicol. Clin. Toxicol. 1996, 34, 405–408. [Google Scholar] [CrossRef] [PubMed]
  106. Poppenga, R.H. Chapter 12—Herbal Medicine: Potential for Intoxication and Interactions with Conventional Drugs. In Veterinary Herbal Medicine; Wynn, S.G., Fougère, B.J., Eds.; Mosby: St. Louis, MO, USA, 2007; pp. 183–207. [Google Scholar]
  107. Simirgiotis, M.J.; Quispe, C.; Areche, C.; Sepúlveda, B. Phenolic Compounds in Chilean Mistletoe (Quintral, Tristerix tetrandus) Analyzed by UHPLC–Q/Orbitrap/MS/MS and Its Antioxidant Properties. Molecules 2016, 21, 245. [Google Scholar] [CrossRef] [Green Version]
  108. Fernández, T.; Wagner, M.L.; Varela, B.G.; Ricco, R.A.; Hajos, S.E.; Gurni, A.A.; Alvarez, E. Study of an Argentine mistletoe, the hemiparasite Ligaria cuneifolia (R. et P.) Tiegh. (Loranthaceae). J. Ethnopharmacol. 1998, 62, 25–34. [Google Scholar] [CrossRef] [PubMed]
  109. Dobrecky, C.B.; Lucangioli, S.E.; Wagner, M.L. The Argentine Mistletoes Ligaria cuneifolia (Ruiz & Pav.) Tiegh (Loranthaceae) and Phoradendron liga (Gillies ex Hook. & Arn.) Eichler (Santalaceae). Thirty Years of Research. Chem. Biodivers. 2022, 19, e202200565. [Google Scholar]
  110. Dobrecky, C.; Marchini, T.; Rafael Ricco, R.; Garcés, M.; Gadano, A.; Carballo, M.; Wagner, M.; Lucangioli, S.; Pablo Evelson, P. Antioxidant Activity of Flavonoid Rich Fraction of Ligaria cuneifolia (Loranthaceae). Chem. Biodivers. 2020, 17, e2000302. [Google Scholar] [CrossRef]
  111. Laiolo, J.; Barbieri, C.L.; Joray, M.B.; Lanza, P.A.; Palacios, S.M.; Mariano, A.; Vera, A.; Carpinella, M.C. Plant extracts and betulin from Ligaria cuneifolia inhibit P-glycoprotein function in leukemia cells. Food Chem. Toxicol. 2021, 147, 111922. [Google Scholar] [CrossRef] [PubMed]
  112. Mauseth, J.D.; Rezaci, K. Morphogenesis in the Parasitic Plant Viscum minimum (Viscaceae) Is Highly Altered, Having Apical Meristems but Lacking Roots, Stems, and Leaves. Int. J. Plant Sci. 2013, 14, 791–801. [Google Scholar] [CrossRef]
  113. Okubamichael, D.; Griffiths, M.E.; Ward, D. Host specificity, nutrient and water dynamics of the mistletoe Viscum rotundifolium and its potential host species in the Kalahari of South Africa. J. Arid. Environ. 2011, 75, 898–902. [Google Scholar] [CrossRef]
  114. Malada, P.M.; Mogashoa, M.M.; Masoko, P. The evaluation of cytotoxic effects, antimicrobial activity, antioxidant activity and combination effect of Viscum rotundifolium and Mystroxylon aethiopicum. S. Afr. J. Bot. 2022, 147, 790–798. [Google Scholar] [CrossRef]
  115. Munteanu, I.G.; Apetrei, C. Analytical Methods Used in Determination of Antioxidant Activity. Int. J. Mol. Sci. 2021, 22, 3380. [Google Scholar] [CrossRef] [PubMed]
  116. Nikolova, M. Screening of radical scavenging activity and polyphenol content of Bulgarian plant species. Pharmacogn. Res. 2011, 3, 256. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  117. Lizcano, L.J.; Fadel, B.; Ruiz-Larrea, B.; Ruiz-Sanz, I.J. Antioxidant activity and polyphenol content of aqueous extracts from Colombian Amazonian plants with medicinal use. Food Chem. 2010, 119, 1566–1570. [Google Scholar] [CrossRef]
  118. Lamichhane, G.; Sharma, G.; Samkota, B.; Adhikari, M.; Ghimire, S.; Poudel, P.; Jung, H.J. Screening of Antioxidant, Antibacterial, Anti-adipogenic, and Antiinflammatory Activities of Five Selected Medicinal Plants of Nepal. J. Exp. Pharmacol. 2023, 15, 93–1010. [Google Scholar] [CrossRef]
  119. Thronicke, A.; Steele, M.L.; Grah, C.; Matthes, B.; Schad, F. Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer. BMC Complement. Altern. Med. 2017, 17, 534. [Google Scholar] [CrossRef] [Green Version]
  120. Schad, F.; Steinmann, D.; Oei, S.L.; Thronicke, A.; Grah, C. Evaluation of quality of life in lung cancer patients receiving radiation and Viscum album L.: A real-world data study. Radiat. Oncol. 2023, 18, 47. [Google Scholar] [CrossRef] [PubMed]
  121. Van der Weijst, L.; Aguado-Barrera, M.E.; Azria, D.; Berkovic, P.; Boisselier, P.; Briers, E.; Bultijnck, R.; Calvo-Crespo, P.; Chang-Claude, J.; Choudhury, A.; et al. Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study). Lung Cancer 2022, 166, 228–241. [Google Scholar] [CrossRef] [PubMed]
  122. Feuer, S.M.; Kuijt, J.; Wiens, D. Fine Structure of pollen Viscum Madagascan and Continental African Viscum L. (Viscaceae). Am. J. Bot. 1982, 69, 163–167. [Google Scholar] [CrossRef]
  123. Vanhaverbeke, C.; Jouboul, D.; Elie, N.; Prévost, M.; Meunier, C.; Michelland, S.; Cumin, V.; Ma, L.; Vermijlen, D.; Delporte, C.; et al. Untarget metabolomics approach to discriminate mistletoe commercial products. Sci. Rep. 2021, 111, 14205. [Google Scholar] [CrossRef]
  124. De Oliveira Melo, M.N.; Clavelland Ochioni, A.; Zancan, P.; Passos Oliveira, A.; Grazi, M.; Garrett, R.; Holandino, C.; Baumgartner, S. Viscum album mother tinctures: Harvest conditions and host trees influence the plant metabolome and the glycolytic pathway of breast cancer cells. Front. Pharmacol. 2022, 13, 1027931. [Google Scholar] [CrossRef]
  125. Zhang, R.-Z.; Zhao, J.-T.; Wang, W.-Q.; Fan, R.-H.; Rong, R.; Yu, Z.-G.; Zhang, Y.-L. Metabolomics-based comparative analysis of the effects of host and environment on Viscum coloratum metabolites and antioxidative activities. J. Pharm. Anal. 2022, 12, 243–252. [Google Scholar] [CrossRef]
  126. Korcan, S.E.; Cankaya, N.; Arzarkhan, S.Y.; Bulduk, I.; Karaaslan, E.C.; Kargioglu, M.; Konik, M.; Guvercin, G. Determination of Antioxidant Activities of Viscum album L.: First Report on Interaction of Phenolics with Survinin Protein using in Silico Analysis. ChemistrySelect 2023, 8, e202300130. [Google Scholar] [CrossRef]
  127. Tabiasco, J.; Pont, F.; Fournié, J.-J.; Vercellone, A. Mistletoe viscotoxins increase natural killer cell mediated cytotoxicity. Eur. J. Biochem. 2002, 269, 2591–2600. [Google Scholar] [CrossRef]
  128. Zwierzina, H.; Bergmann, L.; Fiebig, H.; Aamdal, S.; Schoffski, P.; Wittholm, K.; Lentzen, H. The preclinical and clinical activity of aviscumine: A potential anticancer drug. Eur. J. Cancer 2011, 47, 1450–1457. [Google Scholar] [CrossRef] [PubMed]
  129. Abuharbeid, S.; Apel, J.; Sander, M.; Fiedeler, B.; Langer, M.; Zuzarte, M. Cytotoxicity of the novel anti-cancer drug Viscumin depends on HER-2 levels in SKOV-3 cells. Biochem. Biophys. Res. Commun. 2004, 321, 403–412. [Google Scholar] [CrossRef] [PubMed]
  130. Hong, S.M.; Choi, J.H.; Jo, S.J.; Seong Kyu, S.; Lee, J.M.; Kusakabe, T. Expression of recombinant viscum album coloratum lectin B-chain in the silkworm expression system and evaluation of antioxidant activity. Biotechnol. Bioprocess Eng. 2015, 20, 515–522. [Google Scholar] [CrossRef]
  131. Meyer, A.; Rypniewski, W.; Celewicz, L.; Erdmann, V.A.; Voelter, W.; Singh, T.P.; Genov, N.; Barciszewski, J.; Betzel, C. The mistletoe lectin I—Phloretamide structure reveals a new function of plant lectins. Biochem. Biophys. Res. Commun. 2007, 364, 195–200. [Google Scholar] [CrossRef]
  132. Marvibaigi, M.; Amini, N.; Supriyanto, E.; Abdul Majid, F.A.; Kumar Jaganathan, S.; Jamil, S.; Hamzehalipour Almaki, J.; Nasiri, R. Antioxidant Activity and ROS-Dependent Apoptotic Effect of Scurrula ferruginea (Jack) Danser Methanol Extract in Human Breast Cancer Cell MDA-MB-231. PLoS ONE 2016, 11, e0158942. [Google Scholar] [CrossRef] [Green Version]
  133. Matthes, H.; Thronicke, A.; Holheinz, R.D.; Baars, E.; Martin, D.; Huber, R.; Breitkzeuz, T.; Bar-Sela, G.; Galun, D.; Shad, F. Statement to an Insufficient Systematic Review on Viscum album L. Therapy. Evid.-Based Complement. Altern. Med. 2020, 2020, 7091039. [Google Scholar] [CrossRef] [Green Version]
  134. Melzer, J.; Iten, F.; Hostanska, K.; Saller, R. Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review. Forsch. Komplementmed. 2009, 16, 217–226. [Google Scholar]
  135. Mellor, D. Mistletoe in homoeopathic cancer treatment. Prof. Nurse 1989, 4, 605–607. [Google Scholar]
  136. Stefanucci, A.; Zengin, G.; Llorent-Martinez, E.J.; Dimmito, M.P.; Della Valle, A.; Pieretti, S.; Ak, G.; Sinan, K.-I.; Mollica, A. Viscum album L. homogenizer-assisted and ultrasound-assisted extracts as potential sources of bioactive compounds. J. Food Biochem. 2020, 44, e13377. [Google Scholar] [CrossRef] [PubMed]
  137. Lantos, F.; Ormódi, B.M.; Makra, L.; Hajtó, T.; Süli-Zakar, T.; Krisch, J. Investigation of leafy shoots and tea products of European mistletoe (Viscum album L.) with special focus on their antioxidant capacity. Acta Hortic. Regiotect. 2022, 25, 181–188. [Google Scholar] [CrossRef]
  138. Bonamin, L.V.; Carvalho, A.; Waisse, S. Viscum album (L.) in experimental animal tumours: A meta-analysis. Exp. Ther. Med. 2017, 13, 2723–2740. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  139. Valle, A.C.V.; de Carvalho, A.C. Viscum album in Veterinary Medicine. Int. J. Sci. Res. (IJRS) 2021, 10, 42–49. [Google Scholar]
Plants 12 02707 g001 550
Figure 1. The European mistletoe is most visible in winter on a deciduous tree.
Figure 1. The European mistletoe is most visible in winter on a deciduous tree.
Plants 12 02707 g001
Plants 12 02707 g002 550
Figure 2. The oak mistletoe, Loranthus europaeus, with yellow berries.
Figure 2. The oak mistletoe, Loranthus europaeus, with yellow berries.
Plants 12 02707 g002
Plants 12 02707 g003 550
Figure 3. The berries of the European mistletoe are evident and abundant.
Figure 3. The berries of the European mistletoe are evident and abundant.
Plants 12 02707 g003
Plants 12 02707 g004 550
Figure 4. The structure of visartiside E, with evidence of the prochiral centers (&1) of the molecule.
Figure 4. The structure of visartiside E, with evidence of the prochiral centers (&1) of the molecule.
Plants 12 02707 g004
Table
Table 1. Mistletoe species were investigated for their antioxidant activity, reported are the utilized tests and active constituents.
Table 1. Mistletoe species were investigated for their antioxidant activity, reported are the utilized tests and active constituents.
Mistletoe SpeciesAntioxidant TestsReported Active Constituents
European Mistletoe
Viscum album L.		DPPHFlavonoids
Viscum album L.DPPH, FRAPSeveral
Viscum album L.Effect against oxidative damagePolyphenols
Viscum album L.Variation of enzymes activity (SOD, CAT, GTS)Phenols
Viscum album L.DPPHPolyphenols and phenols
Viscum album L.DPPH and enzymes activity (superoxide anion, HORAC, nitric oxide)Polyphenols and phenols
Viscum album L.enzymes activity (increase in proline content and in superoxide dismutase, ascorbate peroxidase, glutathione peroxidase, and glutathione reductase activity)N.D.
Viscum album L.DPPH, FRAPPolyphenols and phenols
Viscum album L.DPPH and enzymes activity (lipid peroxidation by ferric thiocyanate and hiobarbituric methods)N.D.
Viscum album L.enzymes activity (selectively inhibiting cytokine-induced expression of cyclooxygenase-2) N.D.
Viscum album L.DPPH, ABTS, FRAPQuercetin, rosmarinic acid, catechin
Viscum album L.DPPH, ABTS, AChE activity. total antioxidant capacity, lipid peroxidation assay, hydroxyl radical scavenging activity and enzymes activity (SOD, CAT, GSH-Px, GR, GST, lipid peroxidation levels)Phenols and other
Viscum album L. subsp.
abietis		DPPHPhenols
Korean mistletoe
Viscum album subsp. coloratum L.		DPPHCaffeic acid, oleanoic acid, naringenin, esperetin, betulinic acid, syringaldehyde, and lyoniresinol
Viscum album subsp. coloratum L.DPPH, superoxide radical scavengingFlavonoids
Viscum album subsp. coloratum L.radical scavenging activities toward DPPH and AzBTS-(NH4)2 MicroProtein
Viscum album subsp. coloratum L.DPPH, FRAP, TPCPhenols
Asian mistletoe
Viscum monoicum Roxb. ex DC.		DPPH, ABTSPolyphenols, flavonoids
Viscum articulatum Burn.DPP and enzyme activity (lipopolysaccharide-induced nitric oxide assay)Flavones, visartisides
Viscum articulatum Burn.FRAP, HPSA, DPPH, DRSA and TEACFlavonoids
Viscum liquidambaricolum HayataFRAP, HPSA, DPPH, DRSA and TEACFlavonoids
Viscum articulatum Burn.enzymes activity (inhibition effect on superoxide anion)Flavanones
Indian mistletoe
Dendrophthoe falcata (L.f.) Ettingsh		enzymes activity (inhibiting lipid peroxidation, reduced glutathione, superoxide dismutase levels and increasing CAT activity)N.D.
Chilean mistletoe
Tristerix tetrandus Mart.		DPPH, FRAP, SA Phenols, flavonoids, anthocyanins
Argentinian mistletoe
Ligaria cuneifolia (R. et P.) Tiegh.		DPPHFlavonoids
African mistletoe
Viscum rotundifolium L.f.		DPPH, FRAPPhenols
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Nicoletti, M. The Antioxidant Activity of Mistletoes (Viscum album and Other Species). Plants 2023, 12, 2707. https://doi.org/10.3390/plants12142707

AMA Style

Nicoletti M. The Antioxidant Activity of Mistletoes (Viscum album and Other Species). Plants. 2023; 12(14):2707. https://doi.org/10.3390/plants12142707

Chicago/Turabian Style

Nicoletti, Marcello. 2023. "The Antioxidant Activity of Mistletoes (Viscum album and Other Species)" Plants 12, no. 14: 2707. https://doi.org/10.3390/plants12142707

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop